| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $77.4M | -3.1% |
| Cost of Revenue | $10.7M | -7.6% |
| Gross Profit | $66.7M | -2.4% |
| R&D Expense | $14.6M | -18.8% |
| SG&A Expense | $89.2M | -11.6% |
| Operating Income | -$37.1M | +26.6% |
| Interest Expense | $5.1M | +10.3% |
| Pre-tax Income | -$38.4M | +25.1% |
| Income Tax | $10K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.0M | -23.6% |
| Accounts Receivable | $9.7M | -9.7% |
| Inventory | $7.8M | +22.8% |
| Current Assets | $112.7M | -19.3% |
| Total Assets | $115.3M | -19.3% |
| Current Liabilities | $11.0M | -28.7% |
| Long-term Debt | $42.4M | +5.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.7M | -32.9% |
| Capital Expenditures | $224K | -41.8% |
| Investing Cash Flow | -$224K | +41.8% |
| Financing Cash Flow | $1.8M | -63.9% |
| Free Cash Flow | -$29.9M | -31.6% |
| -95.8% |
| Net Income | -$38.4M | +25.4% |
| EPS (Basic) | -$0.74 | +28.2% |
| EPS (Diluted) | -$0.74 | +28.2% |
| Total Liabilities |
| $51.4M |
| -7.2% |
| Stockholders' Equity | $63.9M | -26.9% |